SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-20-190449
Filing Date
2020-07-09
Accepted
2020-07-09 16:12:29
Documents
5
Effectiveness Date
2020-07-09

Document Format Files

Seq Description Document Type Size
1 DEFA14A d21820ddefa14a.htm DEFA14A 18475
2 GRAPHIC g21820dsp002.jpg GRAPHIC 56908
3 GRAPHIC g21820dsp003.jpg GRAPHIC 80747
4 GRAPHIC g21820dsp004.jpg GRAPHIC 22904
5 GRAPHIC g21820dsp005.jpg GRAPHIC 9795
  Complete submission text file 0001193125-20-190449.txt   236337
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-38906 | Film No.: 201020610
SIC: 2836 Biological Products, (No Diagnostic Substances)